학술논문
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II–III breast cancer
Document Type
Article
Author
Source
In: Oncotarget . (Oncotarget, 2024, 15:238-247)
Subject
Language
English
ISSN
19492553